DUBLIN–(BUSINESS WIRE)–The “Artificial Pancreas – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Artificial Pancreas – Medical Devices Pipeline Assessment, 2020” provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

Scope

• Extensive coverage of the Artificial Pancreas under development
• The report reviews details of major pipeline products which include product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Artificial Pancreas under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

(Read more…)

• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Artificial Pancreas – Pipeline Products by Stage of Development

3.2 Artificial Pancreas – Pipeline Products by Territory

3.3 Artificial Pancreas – Pipeline Products by Regulatory Path

3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date

3.5 Artificial Pancreas – Ongoing Clinical Trials

4 Artificial Pancreas – Pipeline Products under Development by Companies

4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development

4.2 Artificial Pancreas – Pipeline Products by Stage of Development

5 Artificial Pancreas Companies and Product Overview

6 Artificial Pancreas – Recent Developments

7 Appendix

Companies Mentioned

• Admetsys Corp
• Advanced Biosensors-Ohio LLC
• Beta Bionics Inc
• Beta-O2 Technologies Ltd
• Bigfoot Biomedical Inc
• BioTex Inc
• Cerco Medical LLC
• Converge Biotech, Inc.
• Covalor Medical, LLC
• De Montfort University
• Debiotech SA
• Defymed SAS
• Diabeloop SA
• EOFlow Co Ltd
• Giner Inc
• Harvard John A Paulson School of Engineering and Applied Sciences
• Healios Inc
• Imperial College London
• Inreda Diabetic BV
• Insulet Corp
• Joslin Diabetes Center
• Kencak LLC
• McGill University
• Medicsensors SL
• Medtronic Diabetes
• Miromatrix Medical Inc
• Pacific Diabetes Technologies, Inc.
• Pancreum, LLC
• PharmaCyte Biotech Inc
• Polytechnic University of Valencia
• Rensselaer Polytechnic Institute
• Senseonics Holdings Inc
• Stanford University
• Tandem Diabetes Care Inc
• TecMed Inc
• The Alfred Mann Foundation
• TypeZero Technologies LLC
• U-Needle BV
• Universidad Autonoma de Madrid
• University of California San Francisco
• University of California Santa Barbara
• University of Cambridge
• University of Florida
• University of Minnesota
• University of Newcastle
• WaveForm Technologies Inc
• XERIS Pharmaceuticals Inc
• Yale University

For more information about this report visit https://www.researchandmarkets.com/r/mgs0tq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “Artificial Pancreas – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Artificial Pancreas – Medical Devices Pipeline Assessment, 2020” provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

Scope

• Extensive coverage of the Artificial Pancreas under development
• The report reviews details of major pipeline products which include product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Artificial Pancreas under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

(Read more…)

• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Artificial Pancreas – Pipeline Products by Stage of Development

3.2 Artificial Pancreas – Pipeline Products by Territory

3.3 Artificial Pancreas – Pipeline Products by Regulatory Path

3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date

3.5 Artificial Pancreas – Ongoing Clinical Trials

4 Artificial Pancreas – Pipeline Products under Development by Companies

4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development

4.2 Artificial Pancreas – Pipeline Products by Stage of Development

5 Artificial Pancreas Companies and Product Overview

6 Artificial Pancreas – Recent Developments

7 Appendix

Companies Mentioned

• Admetsys Corp
• Advanced Biosensors-Ohio LLC
• Beta Bionics Inc
• Beta-O2 Technologies Ltd
• Bigfoot Biomedical Inc
• BioTex Inc
• Cerco Medical LLC
• Converge Biotech, Inc.
• Covalor Medical, LLC
• De Montfort University
• Debiotech SA
• Defymed SAS
• Diabeloop SA
• EOFlow Co Ltd
• Giner Inc
• Harvard John A Paulson School of Engineering and Applied Sciences
• Healios Inc
• Imperial College London
• Inreda Diabetic BV
• Insulet Corp
• Joslin Diabetes Center
• Kencak LLC
• McGill University
• Medicsensors SL
• Medtronic Diabetes
• Miromatrix Medical Inc
• Pacific Diabetes Technologies, Inc.
• Pancreum, LLC
• PharmaCyte Biotech Inc
• Polytechnic University of Valencia
• Rensselaer Polytechnic Institute
• Senseonics Holdings Inc
• Stanford University
• Tandem Diabetes Care Inc
• TecMed Inc
• The Alfred Mann Foundation
• TypeZero Technologies LLC
• U-Needle BV
• Universidad Autonoma de Madrid
• University of California San Francisco
• University of California Santa Barbara
• University of Cambridge
• University of Florida
• University of Minnesota
• University of Newcastle
• WaveForm Technologies Inc
• XERIS Pharmaceuticals Inc
• Yale University

For more information about this report visit https://www.researchandmarkets.com/r/mgs0tq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900